| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/15/2004 | US6749857 Recombinant dimeric envelope vaccine against flaviviral infection |
| 06/15/2004 | US6749854 Use of OX-2 to inhibit fetal loss |
| 06/15/2004 | US6749853 Combined methods and compositions for coagulation and tumor treatment |
| 06/15/2004 | US6749852 Method for preventing and inhibiting human HLA alloimmune response to platelet transfusion |
| 06/15/2004 | CA2159330C Inhibition of leukocyte adhesion |
| 06/15/2004 | CA2109256C Technetium or rhenium-binding bi-hapten derivatives, a process for their preparation, diagnostic and therapeutic application, and kits and immunological reagents containing same |
| 06/15/2004 | CA2049921C Allergenic proteins from ragweed and uses therefor |
| 06/10/2004 | WO2004048925A2 NaCT AS A TARGET FOR LIFESPAN EXPANSION AND WEIGHT REDUCTION |
| 06/10/2004 | WO2004048574A1 Immunoreceptor proteins |
| 06/10/2004 | WO2004048571A1 Antibody against lesion tissue |
| 06/10/2004 | WO2004048552A2 Modulating immune responses |
| 06/10/2004 | WO2004048525A2 Therapy of non-malignant diseases or disorders with anti-erbb2 antibodies |
| 06/10/2004 | WO2004048517A2 Method for reducing or preventing modification of a polypeptide in solution |
| 06/10/2004 | WO2004048416A1 Monoclonal anti-na, k-atpase-beta-3 subunit antibody p-3e10 and use thereof as a therapeutic agent |
| 06/10/2004 | WO2004048415A1 Identification of tsh receptor autoantibodies using affinity-purified antibodies |
| 06/10/2004 | WO2004048414A2 Holo-transcobalamins binding partners and their use in cobalamin assay |
| 06/10/2004 | WO2004048413A2 Cd55-interaction partners and the uses thereof |
| 06/10/2004 | WO2004048412A2 Method for the generation of antibodies against a desired antigen using preselected animals for immunization |
| 06/10/2004 | WO2004048411A2 Compounds and methods for modulating desmosomal and atypical cadherin-mediated cell adhesion |
| 06/10/2004 | WO2004047865A1 Compositions for the treatment of mycobacterial infections |
| 06/10/2004 | WO2004047864A1 Treatment of skin diseases |
| 06/10/2004 | WO2004047863A2 Genetic products differentially expressed in tumors and the use thereof |
| 06/10/2004 | WO2004047826A1 Combination of diamide derivatives and immunosuppressive agents for induction of immune tolerance |
| 06/10/2004 | WO2004047762A2 Methods for treating cancer using porimin as a target |
| 06/10/2004 | WO2004047761A2 Mbcats as modifiers of the beta-catenin pathway and methods of use |
| 06/10/2004 | WO2004047728A2 Compositions and methods for the treatment of immune related diseases |
| 06/10/2004 | WO2004047720A2 Methods of inhibiting angiogensis via modification of a lysyl oxidase |
| 06/10/2004 | WO2004047612A2 Methods of therapy and diagnosis |
| 06/10/2004 | WO2004039402A3 Prevention and treatment of porcine reproductive and respiratory syndrome with the use of immunoglobulins obtained from the egg yolk from hens hyperimmunised with the prrs virus |
| 06/10/2004 | WO2004031362A8 Multimeric protein engineering |
| 06/10/2004 | WO2004024746A9 Therapeutic anti-bgp(c-cam1) antibodies and uses thereof |
| 06/10/2004 | WO2004017810A3 Tumor specific oligosaccharide epitopes and use thereof |
| 06/10/2004 | WO2004013171A3 Multi-subunit protein production system in transgenic insect |
| 06/10/2004 | WO2004004756A8 Use of pthrp antagonists for treating renal cell carcinoma |
| 06/10/2004 | WO2004004633A3 Use of tnfalpha antibodies and another drug |
| 06/10/2004 | WO2004003144A3 Antibodies that specifically bind to reg iv |
| 06/10/2004 | WO2003089902A3 Displacement assay for detection of small molecules |
| 06/10/2004 | WO2003083039A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 06/10/2004 | WO2003068935A3 Methods of therapy and diagnosis |
| 06/10/2004 | WO2003054142A3 Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
| 06/10/2004 | WO2003040170A9 Antibodies to cd40 |
| 06/10/2004 | WO2003039346A9 Diagnostics and therapeutics for ocular abnormalities |
| 06/10/2004 | WO2003013603A8 Modulators of p-selectin glycoprotein ligand 1 |
| 06/10/2004 | WO2003007800A9 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 06/10/2004 | WO2002090502A3 Highly conserved proteins from gram-positive bacteria |
| 06/10/2004 | WO2002038168A3 Use of selectin-binding active ingredients for the treatment of inflammatory and tumoral diseases |
| 06/10/2004 | US20040111769 Sugar beet genes involved in stress tolerance |
| 06/10/2004 | US20040111763 for introducing DNA into organisms which produce large amounts of oils; genetic engineering; for animal feed, foods, cosmetics and pharmaceuticals; kits |
| 06/10/2004 | US20040111757 Multiplex system for production and screening of monoclonal antibodies |
| 06/10/2004 | US20040110941 by cloning, amplifying and expressing DNA sequences using polymerase chain reaction; for therapy, diagnosis or catalysis; solid phase synthesis |
| 06/10/2004 | US20040110934 Human mitochondrial proteins and polynucleotides encoding the proteins |
| 06/10/2004 | US20040110933 Comprises cartilage link transmembrane protein for diagnosis and treatment of inflammatory, arthritic, restenotic and cell proliferative disorders |
| 06/10/2004 | US20040110931 Prion and viral clearance process |
| 06/10/2004 | US20040110930 Artificial polypeptide comprising immunoglobulin fragments generated in plant; tissue engineering |
| 06/10/2004 | US20040110922 Comprises nucleotide sequences coding viral envelope glycoprotein 120 for diagnosis, prevention and treatment of viral diseases; viricides |
| 06/10/2004 | US20040110919 Comprises toxic jellyfish protein for use as pesticide |
| 06/10/2004 | US20040110774 HIV infection, AIDS, and adenosine deaminase deficiency-dependent severe immunodeficiency disease (ADA SCID); antagonists are antibodies |
| 06/10/2004 | US20040110715 Differs from nucleotide sequence of wild-type IFN alpha -17 gene, in that it comprises one or several SNPs (Single Nucleotide Polymorphism[s]); anticarcinogenic and antiproliferative agents; side effect reduction |
| 06/10/2004 | US20040110706 Nucleic acid with point mutations, deletions, insertions and/or rearrangements ; hyperthermia, myasthenia, ataxia, neuropathic and inflammatory pain; Alzheimer*s, Parkinson's disease; schizophrenia, hyperekplexia, myotonias and arrhythmia |
| 06/10/2004 | US20040110704 Decreased or deleted activity of enzyme with modified sugar chain in which 1-position of fucose is bound to 6-position of N-acetylglucosamine in reducing end; antitumor agents, cardiovascular disorders, autoimmune diseases |
| 06/10/2004 | US20040110677 Stimulating differentiation in growth of osteoblasts and osteoclasts; wound healing of bone fractures and de novo bone formation; osteoporosis; bone cancer treatment; polynucleotide encoding polypeptide; genetic engineering |
| 06/10/2004 | US20040110674 Nucleic acid and corresponding protein entitled 205p1b5 useful in treatment and detection of cancer |
| 06/10/2004 | US20040110673 Treatment of diseases such as diabetes with administering CD83 and T-cells for medical diagnosis and proteins |
| 06/10/2004 | US20040110668 Nucleic acid sequences differentially expressed in cancer tissue |
| 06/10/2004 | US20040110663 Hedgehog antagonists, methods and uses related thereto |
| 06/10/2004 | US20040110284 Monoclonal antibody for use in passive immunization against poisoning/intoxication by botulin toxins |
| 06/10/2004 | US20040110282 Cells in which activity of the protein involved in transportation of GDP-fucose is reduced or lost |
| 06/10/2004 | US20040110269 Protection against mycobacterial infections |
| 06/10/2004 | US20040110268 Attenuated Pasteurellaceae virulence genes are identified and used to screen bactericides and produce vaccines which prevent infection |
| 06/10/2004 | US20040110254 Method for producing alpha-1, 6-branched alph-1, 4-glucans from sucrose |
| 06/10/2004 | US20040110242 reacts with prothrombin forming a complex with phosphatidylserine (PS/PT) but does not react with prothrombin (PT) not forming a complex with phosphatidylserine |
| 06/10/2004 | US20040110239 Detection to the HER2 receptor by means of biotinilated humanized antibody |
| 06/10/2004 | US20040110226 Antibody optimization |
| 06/10/2004 | US20040110218 BMOG, a novel protein member of the myelin-oligodendrocyte glycoprotein family and its use for immunomodulatory purposes |
| 06/10/2004 | US20040110202 Isolated nucleic acid comprising a polynucleotide of given sequence encoding a polypeptide; culturing cell line which alters a beta processing; use in treatment of Alzheimer's disease. |
| 06/10/2004 | US20040110184 Identifying insecticidal protein specific to lepidopteran pests; cry proteins as biological pest control agents |
| 06/10/2004 | US20040110181 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
| 06/10/2004 | US20040110180 Comprises enzymatic polypeptide for diagnosis, treatment and prevention of cardiovascular, immune system, nervous system, lipid and cell proliferative disorders; drug screening |
| 06/10/2004 | US20040110165 Viral chemokine-antigen fusion proteins |
| 06/10/2004 | US20040110127 Screening methods for identifying compounds which decrease HIV entry into a cell |
| 06/10/2004 | US20040109887 Immunogenic proteoliposomes, and uses thereof |
| 06/10/2004 | US20040109866 Immonotherapy complex containing antigen, antibodies, epitopes; binding to receptors |
| 06/10/2004 | US20040109865 Antibody composition-containing medicament |
| 06/10/2004 | US20040109864 induce apoptosis in endothetial cells; binding to annexins; anticancer agents, vuision defects, rheumatic diseases , antidiabetic agents |
| 06/10/2004 | US20040109863 Methods of therapy and diagnosis using targeting of cells that express Ly-9 |
| 06/10/2004 | US20040109862 Methods of therapy and diagnosis using targeting of cells that express Ly-9 |
| 06/10/2004 | US20040109860 Using immunoglobulins that blocks nerve growth factor; therapy for central nervous system disorders |
| 06/10/2004 | US20040109859 Method for the treatment of multiple sclerosis |
| 06/10/2004 | US20040109858 Conformation-specific anti-von Willebrand factor antibodies |
| 06/10/2004 | US20040109857 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 06/10/2004 | US20040109856 Diagnosis, therapy cancer, tumors |
| 06/10/2004 | US20040109855 Prevent binding to protein to therapeutic targets; modifying antibody |
| 06/10/2004 | US20040109849 Dna vaccines expressing hypervariable vh-cdr3 idiotipic determinants |
| 06/10/2004 | US20040109847 Treatment and prophylaxis with 4-1BB-binding agents |
| 06/10/2004 | CA2507338A1 Compositions for the treatment of mycobacterial infections |
| 06/10/2004 | CA2507215A1 Methods for treating cancer using porimin as a target |
| 06/10/2004 | CA2507106A1 Cd55-interaction partners and the uses thereof |
| 06/10/2004 | CA2506666A1 Nact as a target for lifespan expansion and weight reduction |
| 06/10/2004 | CA2506356A1 Methods of therapy and diagnosis |
| 06/10/2004 | CA2506320A1 Therapy of non-malignant diseases or disorders with anti-erbb2 antibodies |